This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Anne Rowzee, PhD
Associate Director, Policy, Office of Tissues & Advanced Therapies(OTAT), Center for Biologics Evaluation & Research (CBER) at U.S. Food and Drug Administration (FDA)

Agenda Sessions

  • Patient Engagement and Regulatory Decision-Making